参考文献/References:
[1] Andrabi SS, Parvez S, Tabassum H. Ischemic stroke and mitochondria: mechanisms and targets[J]. Protoplasma, 2020, 257(2): 335-343.
[2] Schellinger PD, K?rmann M. 4.5-hour time window for intravenous thrombolysis with recombinant tissue-type plasminogen activator is established firmly[J]. Stroke, 2014, 45(3): 912-913.
[3] Gao L, Dong Q, Song Z, et al. NLRP3 inflammasome: a promising target in ischemic stroke[J]. Inflamm Res, 2017, 66(1): 17-24.
[4] Fu C, Zhang X, Lu Y, Wang F, Xu Z, Liu S, Zheng H, Liu X. Geniposide inhibits NLRP3 inflammasome activation via autophagy in BV-2 microglial cells exposed to oxygen-glucose deprivation/reoxygenation[J]. Int Immunopharmacol, 2020, 84:106547.
[5] Fann DY, Lee SY, Manzanero S, et al. Intravenous immunoglobulin suppresses NLRP1 and NLRP3 inflammasome-mediated neuronal death in ischemic stroke[J]. Cell Death Dis, 2013, 4(9): e790.
[6] Swanson KV. DengM,ting JP.the NLRP3 inflammasome:molecular activation and regulation to therapeutics[J]. Nat Rev Immunol, 2019, 19(8): 477-489.
[7] Kelley N, Jeltema D, Duan YH, et al. The NLRP3 inflammasome: an overview of mechanisms of activation and regulation[J]. Int J Mol Sci, 2019, 20(13): 3328.
[8] He Y, Hara H, Nú?z G. Mechanism and regulation of NLRP3 inflammasome activation[J]. Trends Biochem Sci, 2016, 41(12): 1012-1021.
[9] Baker PJ, Boucher D, Bierschenk D, et al. NLRP3 inflammasome activation downstream of cytoplasmic LPS recognition by both caspase-4 and caspase-5[J]. Eur J Immunol, 2015, 45(10): 2918-2926.
[10] Evavold CL, Ruan JB, Tan YH, et al. The Pore-Forming protein gasdermin D regulates interleukin-1 secretion from living macrophages[J]. Immunity, 2018, 48(1): 35.
[11] Gaidt M, Ebert T, Chauhan D, et al. Human monocytes engage an alternative inflammasome pathway[J]. Immunity, 2016, 44(4): 833-846.
[12] Awad F, Assrawi E, Louvrier C, Jumeau C, Georgin-Lavialle S, Grateau G, Amselem S, Giurgea I, Karabina SA. Inflammasome biology, molecular pathology and therapeutic implications[J].Pharmacol Ther, 2018, 187:133-149.
[13] Cao Z, Wang Y, Long Z, et al. Interaction between autophagy and the NLRP3 inflammasome[J]. Acta Biochim Biophys Sin(Shanghai), 2019, 51(11): 1087-1095.
[14] Dupont N, Jiang S, Pilli M, et al. Autophagy-based unconventional secretory pathway for extracellular delivery of IL-1β[J]. EMBO J, 2011, 30(23): 4701-4711.
[15] Fann DY, Santro T, Manzanero SA, et al. Intermittent fasting attenuates inflammasome activity in ischemic stroke[J]. Exp Neurol, 2014, 257:114-119.
[16] Liu L, Cen J, Man Y, et al. Transplantation of human umbilical cord blood mononuclear cells attenuated ischemic injury in MCAO rats via inhibition of NF-κB and NLRP3 inflammasome[J]. Neuroscience, 2018, 369: 314-324.
[17] Fann DY, Lim YA, Cheng YL, et al. Evidence that NF-κB and MAPK Signaling Promotes NLRP Inflammasome Activation in Neurons Following Ischemic Stroke[J]. Mol Neurobiol, 2018, 55(2): 1082-1096.
[18] Qiu J, Wang M, Zhang J, et al. The neuroprotection of Sinomenine against ischemic stroke in mice by suppressing NLRP3 inflammasome via AMPK signaling[J]. Int Immunopharmacol, 2016, 40: 492-500.
[19] Lyons CL, Roche HM. Nutritional modulation of AMPK-Impact upon Metabolic-Inflammation[J]. Int J Mol Sci, 2018, 19(10): 3092.
[20] An P, Xie J, Qiu S, et al. Hispidulin exhibits neuroprotective activities against cerebral ischemia reperfusion injury through suppressing NLRP3-mediated pyroptosis[J]. Life Sci, 2019, 232: 116599.
[21] Guo M, Wang X, Zhao Y, et al. Ketogenic Diet improves brain ischemic tolerance and inhibits NLRP3 inflammasome activation by preventing Drp1-Mediated mitochondrial fission and endoplasmic reticulum stress[J]. Front Mol Neurosci, 2018, 11: 86.
[22] Zhang S, Jiang L, Che F, et al. Arctigenin attenuates ischemic stroke via SIRT1-dependent inhibition of NLRP3 inflammasome[J]. Biochem Biophys Res Commun, 2017, 493(1): 821-826.
[23] Ma DC, Zhang NN, Zhang YN, et al. Kv1.3 Channel blockade alleviates cerebral ischemia/reperfusion injury by reshaping M1/M2 phenotypes and compromising the activation of NLRP3 inflammasome in microglia[J]. Exp Neurol, 2020, 332: 113399.
[24] Feng L, Chen Y, Ding R, et al. P2X7R blockade prevents NLRP3 inflammasome activation and brain injury in a rat model of intracerebral hemorrhage: involvement of peroxynitrite[J]. J Neuroinflammation, 2015, 12: 190.
[25] Yang F, Wang Z, Wei X, et al. NLRP3 deficiency ameliorates neurovascular damage in experimental ischemic stroke[J]. J Cereb Blood Flow Metab, 2014, 34(4): 660-667.
[26] Li X, Shi M, Chen C, et al. Phthalide derivative CD21 ameliorates ischemic brain injury in a mouse model of global cerebral ischemia: involvement of inhibition of NLRP3[J]. Int Immunopharmacol, 2020, 86: 106714.
[27] Li X, Yu Z, Zong W, et al. Deficiency of the microglial Hv1 proton Channel attenuates neuronal pyroptosis and inhibits inflammatory reaction after spinal cord injury[J]. J Neuroinflammation, 2020, 17(1): 263.
[28] Healy LD, Fernández JA, Mosnier LO, et al. Activated protein C and PAR1-derived and PAR3-derived peptides are anti-inflammatory by suppressing macrophage NLRP3 inflammasomes[J]. J Thromb Haemost, 2021, 19(1): 269-280.
[29] Nazir S, Gadi I, Al-Dabet MM, et al. Cytoprotective activated protein C averts Nlrp3 inflammasome-induced ischemia-reperfusion injury via mTORC1 inhibition[J]. Blood, 2017, 130(24): 2664-2677.
[30] Wang Y, Meng C, Zhang J, et al. Inhibition of GSK-3β alleviates cerebral ischemia/reperfusion injury in rats by suppressing NLRP3 inflammasome activation through autophagy[J]. Int Immunopharmacol, 2019, 68: 234-241.
[31] He Q, Li ZY, Wang YE, et al. Resveratrol alleviates cerebral ischemia/reperfusion injury in rats by inhibiting NLRP3 inflammasome activation through Sirt1-dependent autophagy induction[J]. Int Immunopharmacol, 2017, 50: 208-215.
[32] Zhu S, Zhang Z, Jia LQ, et al. Valproic acid attenuates global cerebral ischemia/reperfusion injury in gerbils via anti-pyroptosis pathways[J]. Neurochem Int, 2019, 124: 141-151.
[33] Ye Y, Jin T, Zhang X, et al. Meisoindigo protects against focal cerebral Ischemia-Reperfusion injury by inhibiting NLRP3 inflammasome activation and regulating microglia/macrophage polarization via TLR4/NF-κB signaling pathway[J]. Front Cell Neurosci, 2019, 13:553.
[34] Du X, Xu Y, Chen S, et al. Inhibited CSF1R alleviates ischemia injury via inhibition of microglia M1 polarization and NLRP3 pathway[J]. Neural Plast, 2020, 2020:8825954.
[35] Denes A, Coutts G, Lénárt N, et al. AIM2 and NLRC4 inflammasomes contribute with ASC to acute brain injury independently of NLRP3[J]. Proc Natl Acad Sci U S A, 2015, 112(13): 4050-4055.
[36] Zhou Y, Gu Y, Liu J. BRD4 suppression alleviates cerebral ischemia-induced brain injury by blocking glial activation via the inhibition of inflammatory response and pyroptosis[J]. Biochem Biophys Res Commun, 2019, 519(3): 481-488.
[37] Deroide N, Li X, Lerouet D, et al. MFGE8 inhibits inflammasome-induced IL-1β production and limits postischemic cerebral injury[J]. J Clin Invest, 2013, 123(3): 1176-1181.
[38] Wang QS, Ding HG, Chen SL, et al. Hypertonic saline mediates the NLRP3/IL-1β signaling axis in microglia to alleviate ischemic blood-brain barrier permeability by downregulating astrocyte-derived VEGF in rats[J]. CNS Neurosci Ther, 2020, 26(10): 1045-1057.